Checklist for Informed Consent

Jung Hwan Baek; Auh Whan Park

doi:10.1016/B978-0-323-66127-0.00016-8

Checklist for Informed Consent

Jung Hwan Baek, Auh Whan Park

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Chemical and thermal ablation is a well-known, effective, and safe method for treating benign thyroid nodules and recurrent thyroid cancers. The Korean Society of Thyroid Radiology (KSThR) first introduced thyroid-dedicated devices and basic techniques for thyroid radiofrequency ablation (RFA) in 2012. Thyroid RFA has subsequently been adopted worldwide, and advances in devices and techniques have been made. To optimize treatment efficacy and patient safety, understanding the basic and advanced RFA techniques and selecting the optimal treatment strategy are critical. Therefore the goal of this review is to provide updates and analysis of current devices and advanced techniques for RFA treatment of benign thyroid nodules and recurrent thyroid cancers in comparison with laser ablation (LA) described in the previous version.

Original language	English (US)
Title of host publication	Surgery of the Thyroid and Parathyroid Glands
Publisher	Elsevier
Pages	163-171
Number of pages	9
ISBN (Electronic)	9780323661270
ISBN (Print)	9780323661287
DOIs	https://doi.org/10.1016/B978-0-323-66127-0.00016-8
State	Published - Jan 1 2021
Externally published	Yes

Keywords

guideline
radiofrequency ablation
thyroid
thyroid recurrent cancers
ultrasound

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-323-66127-0.00016-8

Cite this

@inbook{f3f893c4acd24e96980cc0dd9d7b8e2a,

title = "Checklist for Informed Consent",

abstract = "Chemical and thermal ablation is a well-known, effective, and safe method for treating benign thyroid nodules and recurrent thyroid cancers. The Korean Society of Thyroid Radiology (KSThR) first introduced thyroid-dedicated devices and basic techniques for thyroid radiofrequency ablation (RFA) in 2012. Thyroid RFA has subsequently been adopted worldwide, and advances in devices and techniques have been made. To optimize treatment efficacy and patient safety, understanding the basic and advanced RFA techniques and selecting the optimal treatment strategy are critical. Therefore the goal of this review is to provide updates and analysis of current devices and advanced techniques for RFA treatment of benign thyroid nodules and recurrent thyroid cancers in comparison with laser ablation (LA) described in the previous version.",

keywords = "guideline, radiofrequency ablation, thyroid, thyroid recurrent cancers, ultrasound",

author = "Baek, {Jung Hwan} and Park, {Auh Whan}",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-66127-0.00016-8",

language = "English (US)",

isbn = "9780323661287",

pages = "163--171",

booktitle = "Surgery of the Thyroid and Parathyroid Glands",

publisher = "Elsevier",

}

TY - CHAP

T1 - Checklist for Informed Consent

AU - Baek, Jung Hwan

AU - Park, Auh Whan

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Chemical and thermal ablation is a well-known, effective, and safe method for treating benign thyroid nodules and recurrent thyroid cancers. The Korean Society of Thyroid Radiology (KSThR) first introduced thyroid-dedicated devices and basic techniques for thyroid radiofrequency ablation (RFA) in 2012. Thyroid RFA has subsequently been adopted worldwide, and advances in devices and techniques have been made. To optimize treatment efficacy and patient safety, understanding the basic and advanced RFA techniques and selecting the optimal treatment strategy are critical. Therefore the goal of this review is to provide updates and analysis of current devices and advanced techniques for RFA treatment of benign thyroid nodules and recurrent thyroid cancers in comparison with laser ablation (LA) described in the previous version.

AB - Chemical and thermal ablation is a well-known, effective, and safe method for treating benign thyroid nodules and recurrent thyroid cancers. The Korean Society of Thyroid Radiology (KSThR) first introduced thyroid-dedicated devices and basic techniques for thyroid radiofrequency ablation (RFA) in 2012. Thyroid RFA has subsequently been adopted worldwide, and advances in devices and techniques have been made. To optimize treatment efficacy and patient safety, understanding the basic and advanced RFA techniques and selecting the optimal treatment strategy are critical. Therefore the goal of this review is to provide updates and analysis of current devices and advanced techniques for RFA treatment of benign thyroid nodules and recurrent thyroid cancers in comparison with laser ablation (LA) described in the previous version.

KW - guideline

KW - radiofrequency ablation

KW - thyroid

KW - thyroid recurrent cancers

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85136746031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136746031&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-66127-0.00016-8

DO - 10.1016/B978-0-323-66127-0.00016-8

M3 - Chapter

AN - SCOPUS:85136746031

SN - 9780323661287

SP - 163

EP - 171

BT - Surgery of the Thyroid and Parathyroid Glands

PB - Elsevier

ER -

Checklist for Informed Consent

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this